Chickenpox [clinicaltrials_resource:4dd60ef8c8311a922502b55c47e27e2f]
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients [clinicaltrials:NCT00000953]The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children [clinicaltrials:NCT00001054]Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox [clinicaltrials:NCT00001125]A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems [clinicaltrials:NCT00002315]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study of the Safety and Effectiveness of Varivax (the Chicken Pox Vaccine) in Children Who Have Received Kidney Transplants [clinicaltrials:NCT00005009]Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [clinicaltrials:NCT00098046]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients [clinicaltrials:NCT00127608]MMR and Varicella Vaccine in Premature Infants [clinicaltrials:NCT00156559]clinicaltrials:NCT00326183Immune Response to Varicella-Zoster Vaccination and Infection [clinicaltrials:NCT00921999]Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin [clinicaltrials:NCT01684072]Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine [clinicaltrials:NCT01815073]Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine [clinicaltrials:NCT01817270]Varicella-related Hospitalizations in Turkey [clinicaltrials:NCT01887496]Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children [clinicaltrials:NCT01982409]Review of Human Herpes Viruses in Burns [clinicaltrials:NCT02452229]
condition [clinicaltrials_vocabulary:condition]
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients [clinicaltrials:NCT00000953]The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children [clinicaltrials:NCT00001054]Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox [clinicaltrials:NCT00001125]A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems [clinicaltrials:NCT00002315]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study of the Safety and Effectiveness of Varivax (the Chicken Pox Vaccine) in Children Who Have Received Kidney Transplants [clinicaltrials:NCT00005009]Tai Chi Chih and Varicella Zoster Immunity [clinicaltrials:NCT00029484]Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [clinicaltrials:NCT00092430]Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [clinicaltrials:NCT00098046]Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00126997]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients [clinicaltrials:NCT00127608]Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [clinicaltrials:NCT00138255]MMR and Varicella Vaccine in Premature Infants [clinicaltrials:NCT00156559]Evaluation Of Valaciclovir In Patients With Chickenpox [clinicaltrials:NCT00169416]Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox [clinicaltrials:NCT00226499]Immune Responses to Two Dose Varivax +/- MMR-II [clinicaltrials:NCT00258726]clinicaltrials:NCT00326183Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection [clinicaltrials:NCT00338442]Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [clinicaltrials:NCT00351923]Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00352898]Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00353288]Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [clinicaltrials:NCT00406211]Efficacy of TCA Effect on Varicella Atrophic Scars [clinicaltrials:NCT00422539]Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly [clinicaltrials:NCT00432042]Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients [clinicaltrials:NCT00492739]ProQuad® rHA Safety [clinicaltrials:NCT00560755]Study of Two Formulations of GSK Biologicals' Varicella Vaccine [clinicaltrials:NCT00568334]clinicaltrials:NCT00578175The Effectiveness of Varicella Vaccination in Children in Germany [clinicaltrials:NCT00679796]Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [clinicaltrials:NCT00751348]Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). [clinicaltrials:NCT00792623]Safety of a Second Dose of Biken's Varicella Vaccine [clinicaltrials:NCT00830648]clinicaltrials:NCT00839917Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [clinicaltrials:NCT00892775]Immune Response to Varicella-Zoster Vaccination and Infection [clinicaltrials:NCT00921999]Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery [clinicaltrials:NCT00926419]Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [clinicaltrials:NCT00969436]clinicaltrials:NCT00975507
condition browse [clinicaltrials_vocabulary:condition-browse]
Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients [clinicaltrials:NCT00000953]The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children [clinicaltrials:NCT00001054]Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox [clinicaltrials:NCT00001125]A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems [clinicaltrials:NCT00002315]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study of the Safety and Effectiveness of Varivax (the Chicken Pox Vaccine) in Children Who Have Received Kidney Transplants [clinicaltrials:NCT00005009]Tai Chi Chih and Varicella Zoster Immunity [clinicaltrials:NCT00029484]Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [clinicaltrials:NCT00092430]Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [clinicaltrials:NCT00098046]Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00126997]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127010]Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [clinicaltrials:NCT00127023]Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients [clinicaltrials:NCT00127608]Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines [clinicaltrials:NCT00138255]MMR and Varicella Vaccine in Premature Infants [clinicaltrials:NCT00156559]Evaluation Of Valaciclovir In Patients With Chickenpox [clinicaltrials:NCT00169416]Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox [clinicaltrials:NCT00226499]Immune Responses to Two Dose Varivax +/- MMR-II [clinicaltrials:NCT00258726]clinicaltrials:NCT00326183Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection [clinicaltrials:NCT00338442]Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [clinicaltrials:NCT00351923]Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00352898]Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [clinicaltrials:NCT00353288]Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [clinicaltrials:NCT00406211]Efficacy of TCA Effect on Varicella Atrophic Scars [clinicaltrials:NCT00422539]Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly [clinicaltrials:NCT00432042]Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients [clinicaltrials:NCT00492739]ProQuad® rHA Safety [clinicaltrials:NCT00560755]Study of Two Formulations of GSK Biologicals' Varicella Vaccine [clinicaltrials:NCT00568334]clinicaltrials:NCT00578175The Effectiveness of Varicella Vaccination in Children in Germany [clinicaltrials:NCT00679796]Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [clinicaltrials:NCT00751348]Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). [clinicaltrials:NCT00792623]Safety of a Second Dose of Biken's Varicella Vaccine [clinicaltrials:NCT00830648]clinicaltrials:NCT00839917Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [clinicaltrials:NCT00892775]Immune Response to Varicella-Zoster Vaccination and Infection [clinicaltrials:NCT00921999]Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery [clinicaltrials:NCT00926419]Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [clinicaltrials:NCT00969436]clinicaltrials:NCT00975507
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Chickenpox [clinicaltrials_resource:4dd60ef8c8311a922502b55c47e27e2f]
Bio2RDF identifier
4dd60ef8c8311a922502b55c47e27e2f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4dd60ef8c8311a922502b55c47e27e2f
identifier
clinicaltrials_resource:4dd60ef8c8311a922502b55c47e27e2f
title
Chickenpox
@en
type
label
Chickenpox [clinicaltrials_resource:4dd60ef8c8311a922502b55c47e27e2f]
@en
Chickenpox